Search results
EHRA 2019: Internal vs. External Electrical Cardioversion of Atrail Arrhythmias in Patients With an…
Author(s):
Jakob Luker
Added:
4 years ago
Video
Paul Kalra
Job title: Professor
Author
Author(s):
William Foster
,
Mark Sopher
Added:
3 years ago
In 1966, following the death of his mentor Professor Harry Heller from ventricular tachycardia (VT), Michel Mirowski began to research a way to prevent future deaths from ventricular arrhythmia, working with Morton Mower and William Staewen in Sinai Hospital, Baltimore. The first human implant of an automated implanted cardioverter defibrillator (ICD) took place in 1980 amid much criticism and…
View more
Author(s):
Derk Jan ten Harkel
,
Maarten Witsenburg
Added:
3 years ago
In recent years, there have been many advances in the diagnosis and treatment of arrhythmias in children. This paper focuses on some of these advances, and gives an overview of relevant studies. Special attention is paid to technological advances that have created the possibility of using devices like an implantable loop recorder or an implantable cardioverter-defibrillator (ICD) in even small…
View more
Author(s):
Jordi Perez-Rodon
,
Enrique Galve
,
Carmen Pérez-Bocanegra
,
et al
Added:
3 years ago
Topic: 3. Heart Failure and Cardiomyopathy
Introduction and Objectives
Although treatment optimization in patients with heart failure and reduced left ventricular ejection fraction (HFrEF) may result in left ventricular reverse remodelling (LVRR) in some cases, predictors of this phenomenon are scarce. This study aimed to: 1) determine the incidence and predictors of absence of LVRR after…
View more
Author(s):
Alessandro Marinelli
,
Mario Luzi
,
Alessandro Capucci
Added:
3 years ago
Several randomised controlled trials (RCTs) have proven the efficacy of the implantable cardioverter-defibrillator (ICD) in preventing sudden cardiac death (SCD) in patients with advanced systolic heart failure (HF) and reduced left ventricular ejection fraction (LVEF).1–3 ICD therapy proved to be efficacious also in other conditions at high risk for arrhythmic death such as familial SCD…
View more
Author(s):
Derek V Exner
Added:
3 years ago
Why Do We Need Risk Stratification Tools?
Sudden death accounts for between 300,000 and 500,000 deaths each year in North America.1 Patients with a history of myocardial infarction (MI) have a four-fold higher risk of sudden death than those without such a history. Most sudden deaths in ambulatory populations result from life-threatening ventricular arrhythmias that lead to a cardiac arrest.2…
View more
Author(s):
Vincent Floré
,
Rik Willems
Added:
3 years ago
Sudden cardiac arrest (SCA) can be defined as the abrupt cessation of cardiac activity due to an underlying cardiac cause, occurring instantaneously in a previously stable patient and in the absence of non-cardiovascular causes (e.g., trauma, intoxication, drowning, electrocution).1,2 SCA will lead to loss of consciousness within the minute due to insufficient cerebral perfusion. If no immediate…
View more
Remote Patient Monitoring in Cardiac Rhythm Management - An Imminent Change for Device Follow-up
Author(s):
Dominic AMJ Theuns
,
Luc J Jordaens
Added:
3 years ago
Article
Author(s):
Dan Wichterle
Added:
3 years ago
Myocardial infarction (MI) is associated with acute risk of early malignant arrhythmias that can be easily treated during in-hospital intensive care by defibrillation, adjuvant antiarrhythmic therapy or even catheter ablation in resistant cases. Indeed, such management resulted in substantial improvement in MI survival rate. Despite the implementation of primary percutaneous coronary…
View more